TruAlt Bioenergy · NSE: TRUALT · BSE: 544545
Q2 FY26 results · Jul–Sep 2025
TruAlt Bioenergy reported revenue from operations of ₹114.86 crore and net loss of ₹37.94 crore for Q2 FY26 (Jul–Sep 2025), on a consolidated basis.
| Item | Q2 FY26 | Q2 FY25 | YoY | Q1 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 114.86 | — | — | 303.89 | −62.2% |
| Other income | 14.76 | — | — | 22.74 | −35.1% |
| Total income | 129.61 | — | — | 326.63 | −60.3% |
| Profit before tax | (49.18) | — | — | 5.80 | Turned loss |
| Net profit for the period | (37.94) | — | — | 4.73 | Turned loss |
| Attributable to shareholders of the company | (37.86) | — | — | 4.73 | Turned loss |
| EPS, basic (₹) | (5.37) | — | — | 0.67 | not comparable |
| Net margin (%) | -33.0 | — | 1.6 |
| Item | Q2 FY26 | Q2 FY25 | YoY | Q1 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 104.47 | — | — | 293.93 | −64.5% |
| Other income | 14.63 | — | — | 22.56 | −35.2% |
| Total income | 119.10 | — | — | 316.49 | −62.4% |
| Profit before tax | (55.48) | — | — | 0.13 | Turned loss |
| Net profit for the period | (42.75) | — | — | 0.03 | Turned loss |
| EPS, basic (₹) | (6.04) | — | — | 0.00 | not comparable |
| Net margin (%) | -40.9 | — | 0.0 |
Consolidated
- Filed with BSE
- 12 Nov 2025, 13:01 IST
- Board meeting
- 11 Nov 2025
- Period
- 01 Jul 2025 to 30 Sep 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 12 Nov 2025, 13:01 IST
- Board meeting
- 11 Nov 2025
- Period
- 01 Jul 2025 to 30 Sep 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE